These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 31211168

  • 21. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.
    Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I, Huntington Study Group.
    Neurology; 2009 Aug 04; 73(5):385-92. PubMed ID: 19652143
    [Abstract] [Full Text] [Related]

  • 22. Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.
    Huntington Study Group COHORT InvestigatorsDepartment of Neurology, Johns Hopkins Medicine, Baltimore, Maryland, United States of America. ray.dorsey@jhmi.edu, Dorsey E.
    PLoS One; 2012 Aug 04; 7(2):e29522. PubMed ID: 22359536
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles).
    Semaka A, Collins JA, Hayden MR.
    Am J Med Genet B Neuropsychiatr Genet; 2010 Jan 05; 153B(1):314-20. PubMed ID: 19455596
    [Abstract] [Full Text] [Related]

  • 25. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H, Bohlen S, Saft C, Hoffmann R, Gerss J, Muratori L, Ringelstein EB, Landwehrmeyer GB, Reilmann R.
    Gait Posture; 2018 May 05; 62():451-457. PubMed ID: 29660633
    [Abstract] [Full Text] [Related]

  • 26. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?
    Herishanu YO, Parvari R, Pollack Y, Shelef I, Marom B, Martino T, Cannella M, Squitieri F.
    J Neurol Sci; 2009 Feb 15; 277(1-2):143-6. PubMed ID: 19059613
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J, Zidovská J, Stochl J, Ing VK, Uhrová T, Roth J.
    Mov Disord; 2011 Jan 15; 26(1):125-9. PubMed ID: 21322024
    [Abstract] [Full Text] [Related]

  • 29. Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.
    Petracca M, Di Tella S, Solito M, Zinzi P, Lo Monaco MR, Di Lazzaro G, Calabresi P, Silveri MC, Bentivoglio AR.
    Eur J Neurol; 2022 Jul 15; 29(7):1940-1951. PubMed ID: 35357736
    [Abstract] [Full Text] [Related]

  • 30. The diagnosis and natural history of Huntington disease.
    Pagan F, Torres-Yaghi Y, Altshuler M.
    Handb Clin Neurol; 2017 Jul 15; 144():63-67. PubMed ID: 28947126
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
    Cao GN, Bao XH, Lu HM, Zhang JJ, Ma YN, Gu WH, Xiong H, Qin J, Wu XR.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr 18; 43(2):163-7. PubMed ID: 21503105
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, TRACK-HD investigators.
    Lancet Neurol; 2012 Jan 18; 11(1):42-53. PubMed ID: 22137354
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Huntington disease: DNA analysis in Brazilian population.
    Raskin S, Allan N, Teive HA, Cardoso F, Haddad MS, Levi G, Boy R, Lerena Junior J, Sotomaior VS, Janzen-Dück M, Jardim LB, Fellander FR, Andrade LA.
    Arq Neuropsiquiatr; 2000 Dec 18; 58(4):977-85. PubMed ID: 11105061
    [Abstract] [Full Text] [Related]

  • 38. Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal Outcomes.
    Garcia TP, Wang Y, Shoulson I, Paulsen JS, Marder K.
    J Huntingtons Dis; 2018 Dec 18; 7(4):337-344. PubMed ID: 30400103
    [Abstract] [Full Text] [Related]

  • 39. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C, European HD Network.
    Neurology; 2016 Aug 09; 87(6):571-8. PubMed ID: 27402890
    [Abstract] [Full Text] [Related]

  • 40. Epidemiology of Huntington disease.
    Kay C, Hayden MR, Leavitt BR.
    Handb Clin Neurol; 2017 Aug 09; 144():31-46. PubMed ID: 28947124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.